Ketamine has been hailed as a fast-acting, effective treatment for major depression. But new research questions whether the ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a ...
According to an article in the June 2022 issue of Psychiatry Research, "Replicated clinical trials have demonstrated rapid and robust antidepressant effects with ketamine in treatment-resistant mood ...
Roughly one in ten Americans suffers from major depressive disorder (MDD) at any given time. In total, up to 20 percent of people will deal with its symptoms at some point in their lives. Despite its ...
The Food and Drug Administration on Tuesday approved a form of ketamine, which is a rapid acting anesthetic that has been used illegally as a party drug known as "Special K," as a treatment for ...
MedPage Today on MSN
Low-dose buprenorphine enhanced ketamine's antisuicidal effects in major depression
Study shows larger reduction in suicidal ideation scores with buprenorphine versus placebo ...
Some people are turning to an alternative treatment for depression that's typically known in a very different context. About ...
OMAHA, Neb. (WOWT) - A Fremont mother says ketamine infusion therapy has improved her chronic pain and mental health after traditional treatments failed to provide relief. Elanor Koch’s health ...
Carly Schwartz wanted a solution for her mental health struggles. She found one, but not where she expected ...
Clinics offering ketamine infusions and injections for “treatment-resistant depression” are today claiming 24-48 hours remission, and ketamine is also being marketed for post-traumatic stress disorder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results